Inspired? If you’re an Early Career Researcher you could win a £500 grant to share your research at an academic conference. Next deadline is 28th February 2018

Apply now

Scientists have identified a bacterial strain that can be used against prostate cancer. This is a new example of how bacteria’s anti-tumour properties can be enlisted in designing new cancer therapies.

Read More

Researchers have linked the damaging inflammation observed after a heart attack to an incorrect immune response. Targeting the cells that are involved can help people recover faster.

Read More

For a long time, scientists have noted the similarity between the hepatitis B virus and HIV. A recent discovery in hepatitis B could take them closer to developing a HIV vaccine.

Read More

Scientists are getting closer to a treatment for HIV patients that doesn’t require taking drugs daily. They have achieved promising results using compounds that track and suppress the HIV better than current antiretroviral drugs.

Read More

Scientists building on earlier research into stem cells have managed to halt multiple sclerosis (MS) in a clinical trial, but the treatment is not suitable for patients with an advanced stage of the disease.

Read More

The dysfunction of cells' energy generators - the mitochondria - plays a key role in multiple sclerosis and offers new ways of treatment.

Read More

Mounting evidence points to a link between the make-up of the gut microbiome and multiple sclerosis (MS). Tweaking our bacterial mix can pave the way for new therapies.

Read More

Antibodies are a new alternative to anti-inflammatory drugs for curbing the progress of MS and letting patients enjoy their lives. They work by neutralising the ‘misguided’ immune cells associated with the disease.

Read More

Posts by Tag

see all